SAB Biotherapeutics, Inc. (NasdaqCM: SABS)
Health Care · Biotechnology · US
$2.98
0.00% today · +29.0% 1Y
SAB Biotherapeutics, Inc. (NasdaqCM: SABS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $271.14M and employs 86 people.
Over the last twelve months the share price has gained 29.0%, trading between 2.10 and 5.15.
Tweenvest scores SAB Biotherapeutics, Inc. across four factors: quality 45/100, value 82/100. Its strongest factor is value.
SABS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $271.14M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.56
- Dividend yield
- —
- Beta (5Y)
- 0.58
- 52-week high
- $5.15
- 52-week low
- $2.10
- Avg volume (3M)
- —
- Shares outstanding
- 90.99M
- Employees
- 86
- Next earnings
- —
About SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.
- ISIN
- US78397T2024
- Founded
- 2014
- Listed since
- Feb 9, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Clinuvel Pharmaceuticals LimitedASX: CUV | $279.41M | AU$7.94 | +0.13% |
| Larimar Therapeutics, Inc.NasdaqGM: LRMR | $278.70M | $2.67 | -9.80% |
| Vanda Pharmaceuticals Inc.NasdaqGM: VNDA | $276.31M | $4.57 | -1.30% |
| Bicycle Therapeutics plcNasdaqGS: BCYC | $272.27M | $3.89 | +2.10% |
| Palisade Bio, Inc.NasdaqCM: PALI | $268.38M | $1.54 | +6.94% |
| Northwest Biotherapeutics, Inc.OTCPK: NWBO | $267.79M | $0.16 | +2.15% |
| Century Therapeutics, Inc.NasdaqCM: IPSC | $266.18M | $1.47 | -3.92% |
| Mabpharm LimitedSEHK: 2181 | $265.39M | HK$0.51 | +3.06% |
Figures last refreshed Oct 11, 2026.